Evidence map›Paper›PMID 31096915›Full record

ArticleBMC cardiovascular disorders2019

The influence of calcium-phosphate metabolism abnormalities on the quality of life in patients with hemodynamically significant mitral regurgitation.

Olga Mozenska, Jacek Bil, Agnieszka Segiet, Dariusz A Kosior

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cardiovascular disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Olga MozenskaDepartment of Cardiology and Hypertension, Central Clinical Hospital of the Ministry of the Interior and Administration, Woloska Street 137, 02-507, Warsaw, Poland. olgamozenska@gmail.com.
Jacek BilDepartment of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of the Interior and Administration, Woloska Street 137, 02-507, Warsaw, Poland.ORCID 0000-0002-8724-5611
Agnieszka SegietDepartment of Cardiology and Hypertension, Central Clinical Hospital of the Ministry of the Interior and Administration, Woloska Street 137, 02-507, Warsaw, Poland.
Dariusz A KosiorDepartment of Applied Physiology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawinskiego Street 5, 02-106, Warsaw, Poland.
Central Clinical Hospital · PLMedical University of Warsaw · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, studies have indicated that vitamin D [25(OH)D

methodsWe included 99 patients with significant MR (median age, 75 years [Q1-Q3, 66.0-81.5], 35.4% females). Hemodynamically significant MR was assessed using transthoracic echocardiography (vena contracta > 3 mm, effective orifice area > 0.2 cm

resultsA significant negative correlation between parathormone (PTH) levels and HRQoL was demonstrated (r = - 0.242, - 0.243, and - 0.255; p = 0.018, 0.018, and 0.013 for Global Scores, and physical and social domains, respectively). Additionally, we confirmed that patients with higher NT-proBNP levels, NYHA heart failure (HF) class, and larger left ventricles had poorer HRQoL. Moreover, patients with poorer HRQoL walked a shorter distance in a 6-min walking test.

conclusionsTo the best of our knowledge, this report is the first to show that Ca-P abnormalities resulted in significantly worse HRQoL, especially in the physical domain, in a population of patients with hemodynamically significant MR.

Indexed as

HemodynamicsQuality of LifeAgedAged, 80 and overBiomarkersCalciumExercise ToleranceFemaleHumansMaleMitral ValveMitral Valve InsufficiencyNatriuretic Peptide, BrainParathyroid HormonePeptide FragmentsPhosphatesBiomarkersCalciumNatriuretic Peptide, BrainParathyroid HormonePeptide FragmentsPhosphatespro-brain natriuretic peptide (1-76)PTH protein, humanHealth-related quality of lifeHypocalcemiaMacNewparathormoneQuality of lifeValvular heart diseaseVitamin D

Identifiers

PMID31096915
PMCPMC6521542
OpenAlexW2947800673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.